JPM | Free Full-Text | Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Rituximab for the treatment of multiple sclerosis: a review | SpringerLink
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Rituximab (Rituxan) | American Journal of Neuroradiology
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Rituximab - Wikipedia
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
B-Cell Targeted Therapies: Clinical Trials Update
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Rituximab in neurological disease: principles, evidence and practice | Practical Neurology
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Rituximab - Wikipedia
The value of rituximab treatment in primary Sjögren's syndrome - ScienceDirect
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Biological Therapy for Rheumatoid Arthritis - ppt download
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Rituximab mode of action: apoptosis and ADCC. Rituximab mediated... | Download Scientific Diagram
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
